Mirae Asset Global Investments Co. Ltd. Sells 28,648 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Mirae Asset Global Investments Co. Ltd. decreased its stake in Teladoc Health, Inc. (NYSE:TDOC) by 16.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 148,909 shares of the health services provider’s stock after selling 28,648 shares during the period. Mirae Asset Global Investments Co. Ltd. owned 0.09% of Teladoc Health worth $3,209,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of TDOC. MetLife Investment Management LLC acquired a new stake in Teladoc Health in the 1st quarter valued at about $218,000. Panagora Asset Management Inc. lifted its stake in Teladoc Health by 18.8% in the 1st quarter. Panagora Asset Management Inc. now owns 16,710 shares of the health services provider’s stock valued at $1,205,000 after purchasing an additional 2,640 shares during the last quarter. Rhumbline Advisers lifted its stake in Teladoc Health by 2.3% in the 1st quarter. Rhumbline Advisers now owns 130,916 shares of the health services provider’s stock valued at $9,443,000 after purchasing an additional 2,921 shares during the last quarter. Great West Life Assurance Co. Can lifted its stake in Teladoc Health by 10.8% in the 1st quarter. Great West Life Assurance Co. Can now owns 107,908 shares of the health services provider’s stock valued at $8,237,000 after purchasing an additional 10,559 shares during the last quarter. Finally, Raymond James Trust N.A. lifted its stake in Teladoc Health by 7.8% in the 1st quarter. Raymond James Trust N.A. now owns 11,451 shares of the health services provider’s stock valued at $826,000 after purchasing an additional 827 shares during the last quarter. Institutional investors own 76.82% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently issued reports on TDOC. DA Davidson cut their target price on shares of Teladoc Health from $22.00 to $18.00 and set a “neutral” rating for the company in a research note on Wednesday, February 21st. Royal Bank of Canada cut their price objective on shares of Teladoc Health from $30.00 to $25.00 and set an “outperform” rating for the company in a research report on Wednesday, February 21st. Cantor Fitzgerald initiated coverage on shares of Teladoc Health in a research report on Thursday, February 29th. They set an “overweight” rating and a $22.00 price objective for the company. Barclays cut their price objective on shares of Teladoc Health from $26.00 to $25.00 and set an “overweight” rating for the company in a research report on Wednesday, February 21st. Finally, Truist Financial cut their price objective on shares of Teladoc Health from $23.00 to $17.00 and set a “hold” rating for the company in a research report on Wednesday, March 6th. Eight analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $22.23.

Insider Activity at Teladoc Health

In related news, CAO Richard J. Napolitano sold 3,765 shares of Teladoc Health stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $54,667.80. Following the transaction, the chief accounting officer now directly owns 18,077 shares of the company’s stock, valued at $262,478.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CAO Richard J. Napolitano sold 3,765 shares of Teladoc Health stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $54,667.80. Following the transaction, the chief accounting officer now directly owns 18,077 shares of the company’s stock, valued at $262,478.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Arnnon Geshuri sold 7,500 shares of Teladoc Health stock in a transaction that occurred on Monday, March 25th. The shares were sold at an average price of $15.06, for a total transaction of $112,950.00. Following the completion of the transaction, the insider now directly owns 38,470 shares in the company, valued at $579,358.20. The disclosure for this sale can be found here. Insiders have sold 135,441 shares of company stock valued at $2,038,251 over the last three months. 1.63% of the stock is owned by insiders.

Teladoc Health Price Performance

Shares of TDOC opened at $13.14 on Thursday. Teladoc Health, Inc. has a 12 month low of $13.03 and a 12 month high of $30.41. The firm’s 50 day moving average is $15.89 and its 200-day moving average is $17.98. The company has a quick ratio of 3.47, a current ratio of 3.54 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Tuesday, February 20th. The health services provider reported ($0.17) EPS for the quarter, topping the consensus estimate of ($0.22) by $0.05. Teladoc Health had a negative net margin of 8.47% and a negative return on equity of 9.22%. The company had revenue of $660.50 million for the quarter, compared to analysts’ expectations of $670.79 million. During the same period last year, the firm earned ($0.23) earnings per share. The business’s revenue for the quarter was up 3.6% on a year-over-year basis. On average, analysts expect that Teladoc Health, Inc. will post -1.07 EPS for the current year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.